CLBAX
Price
$40.09
Change
-$0.08 (-0.20%)
Updated
Jul 24 closing price
Net Assets
288.09B
CSIFX
Price
$48.00
Change
-$0.02 (-0.04%)
Updated
Jul 24 closing price
Net Assets
1.47B
Interact to see
Advertisement

CLBAX vs CSIFX

CLBAX vs CSIFX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. CSIFX commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Buy and CSIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 288B vs. CSIFX (1.47B). CLBAX pays higher dividends than CSIFX: CLBAX (1.79) vs CSIFX (1.29). CLBAX was incepted earlier than CSIFX: CLBAX (24 years) vs CSIFX (44 years). CSIFX (0.90) is less costly to investors than CLBAX (0.58). CSIFX is a more actively managed with annual turnover of: 164.00 vs. CLBAX (50.00). CSIFX initial investment is less costly to investors than CLBAX (4%) vs CLBAX (4%). CLBAX has a lower initial minimum investment than CSIFX: CLBAX (250) vs CSIFX (1000). CLBAX annual gain was more profitable for investors over the last year : 10.36 vs. CSIFX (4.08). CLBAX return over 5 years is better than : 33.49 vs. CSIFX (19.56).
CLBAXCSIFXCLBAX / CSIFX
Total Expense Ratio0.580.9064%
Annual Report Gross Expense Ratio0.580.9064%
Fund Existence24 years44 years-
Gain YTD7.7852.454317%
Front Load4%5%67%
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B1.47B19,605%
Annual Yield % from dividends1.791.29139%
Returns for 1 year10.364.08254%
Returns for 3 years37.7032.78115%
Returns for 5 years33.4919.56171%
Returns for 10 years91.1978.86116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEAIX32.200.24
+0.75%
First Eagle Rising Dividend Fund I
EMGAX38.97N/A
N/A
Allspring Emerging Markets Equity A
BIPIX90.51N/A
N/A
ProFunds Biotechnology UltraSector Inv
TRBCX204.44N/A
N/A
T. Rowe Price Blue Chip Growth
GGHSX42.48N/A
N/A
Invesco Health Care R6